Open AccessIntermediate Syndrome After Organophosphate Ingestion
Author(s) -
YenTa Huang,
PeiChun Lai,
Chien Wei Su,
Yi-Ting Chen,
Chuan-Zhong Cai,
ChihHsien Wang
Publication year - 2007
Publication title -
tzu-chi medical journal/cí-jì yīxué
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.343
H-Index - 15
eISSN - 2223-8956
pISSN - 1016-3190
DOI - 10.1016/s1016-3190(10)60009-2
Subject(s) - medicine , organophosphate poisoning , acetylcholinesterase , organophosphate , acetylcholine , cholinergic , downregulation and upregulation , nicotinic agonist , neuromuscular junction , acetylcholine receptor , respiratory failure , nicotinic acetylcholine receptor , pharmacology , anesthesia , neuroscience , receptor , biochemistry , enzyme , chemistry , biology , pesticide , gene , agronomy
Organophosphate poisoning is not uncommon in Taiwan. However, no case of intermediate syndrome (IMS) has been published. We report a case of delayed-onset IMS presenting with abrupt respiratory failure following the acute cholinergic crisis of phenthoate poisoning. Based on electrophysi-ological studies from the literature, IMS results from an excess amount of acetylcholine at neuromuscular junction nicotinic acetylcholine receptors due to prolonged inhibition of acetylcholinesterase. This phenomenon leads to downregulation of the acetylcholine receptor and promotes muscle weakness. There are still no appropriate parameters to predict the development of IMS. Perhaps electrophysiological studies can be applied in the future. Ventilatory support is the most important treatment; the benefits of pra-lidoxime treatment are still controversial. IMS is still a challenging complication of organophosphate poisoning. Physicians should not overlook IMS